60 Degrees Pharmaceuticals (SXTPW) Enterprise Value (2022 - 2025)
Historic Enterprise Value for 60 Degrees Pharmaceuticals (SXTPW) over the last 4 years, with Q3 2025 value amounting to -$4.2 million.
- 60 Degrees Pharmaceuticals' Enterprise Value rose 1748.61% to -$4.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$4.2 million, marking a year-over-year increase of 1748.61%. This contributed to the annual value of -$5.2 million for FY2024, which is 13467.32% down from last year.
- According to the latest figures from Q3 2025, 60 Degrees Pharmaceuticals' Enterprise Value is -$4.2 million, which was up 1748.61% from -$2.0 million recorded in Q2 2025.
- 60 Degrees Pharmaceuticals' Enterprise Value's 5-year high stood at -$29993.0 during Q1 2023, with a 5-year trough of -$5.2 million in Q4 2024.
- For the 4-year period, 60 Degrees Pharmaceuticals' Enterprise Value averaged around -$2.3 million, with its median value being -$2.1 million (2023).
- Per our database at Business Quant, 60 Degrees Pharmaceuticals' Enterprise Value surged by 2070.01% in 2023 and then plummeted by 979971.99% in 2024.
- Quarter analysis of 4 years shows 60 Degrees Pharmaceuticals' Enterprise Value stood at -$837185.0 in 2022, then crashed by 164.52% to -$2.2 million in 2023, then crashed by 134.67% to -$5.2 million in 2024, then rose by 19.2% to -$4.2 million in 2025.
- Its Enterprise Value stands at -$4.2 million for Q3 2025, versus -$2.0 million for Q2 2025 and -$3.5 million for Q1 2025.